NM_000376.3:c.1025-95G>A
Variant names:
Variant summary
Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1
The NM_000376.3(VDR):c.1025-95G>A variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0428 in 1,580,452 control chromosomes in the GnomAD database, including 2,078 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.072 ( 627 hom., cov: 29)
Exomes 𝑓: 0.040 ( 1451 hom. )
Consequence
VDR
NM_000376.3 intron
NM_000376.3 intron
Scores
2
Clinical Significance
Conservation
PhyloP100: -2.20
Publications
10 publications found
Genes affected
VDR (HGNC:12679): (vitamin D receptor) This gene encodes vitamin D3 receptor, which is a member of the nuclear hormone receptor superfamily of ligand-inducible transcription factors. This receptor also functions as a receptor for the secondary bile acid, lithocholic acid. Downstream targets of vitamin D3 receptor are principally involved in mineral metabolism, though this receptor regulates a variety of other metabolic pathways, such as those involved in immune response and cancer. Mutations in this gene are associated with type II vitamin D-resistant rickets. A single nucleotide polymorphism in the initiation codon results in an alternate translation start site three codons downstream. Alternatively spliced transcript variants encoding different isoforms have been described for this gene. A recent study provided evidence for translational readthrough in this gene, and expression of an additional C-terminally extended isoform via the use of an alternative in-frame translation termination codon. [provided by RefSeq, Jun 2018]
VDR Gene-Disease associations (from GenCC):
- vitamin D-dependent rickets, type 2AInheritance: AR Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), G2P
- vitamin D-dependent rickets, type 2Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -20 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.88).
BP6
Variant 12-47845100-C-T is Benign according to our data. Variant chr12-47845100-C-T is described in ClinVar as Benign. ClinVar VariationId is 1251714.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.149 is higher than 0.05.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0714 AC: 10799AN: 151186Hom.: 621 Cov.: 29 show subpopulations
GnomAD3 genomes
AF:
AC:
10799
AN:
151186
Hom.:
Cov.:
29
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome AF: 0.0397 AC: 56806AN: 1429148Hom.: 1451 AF XY: 0.0396 AC XY: 28218AN XY: 712236 show subpopulations
GnomAD4 exome
AF:
AC:
56806
AN:
1429148
Hom.:
AF XY:
AC XY:
28218
AN XY:
712236
show subpopulations
African (AFR)
AF:
AC:
5490
AN:
33086
American (AMR)
AF:
AC:
1746
AN:
44500
Ashkenazi Jewish (ASJ)
AF:
AC:
545
AN:
25846
East Asian (EAS)
AF:
AC:
64
AN:
39616
South Asian (SAS)
AF:
AC:
3580
AN:
85138
European-Finnish (FIN)
AF:
AC:
2392
AN:
39236
Middle Eastern (MID)
AF:
AC:
244
AN:
4174
European-Non Finnish (NFE)
AF:
AC:
40067
AN:
1098022
Other (OTH)
AF:
AC:
2678
AN:
59530
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.499
Heterozygous variant carriers
0
2912
5824
8735
11647
14559
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Exome Het
Exome Hom
Variant carriers
0
1550
3100
4650
6200
7750
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.0716 AC: 10829AN: 151304Hom.: 627 Cov.: 29 AF XY: 0.0712 AC XY: 5261AN XY: 73918 show subpopulations
GnomAD4 genome
AF:
AC:
10829
AN:
151304
Hom.:
Cov.:
29
AF XY:
AC XY:
5261
AN XY:
73918
show subpopulations
African (AFR)
AF:
AC:
6239
AN:
41054
American (AMR)
AF:
AC:
916
AN:
15234
Ashkenazi Jewish (ASJ)
AF:
AC:
75
AN:
3468
East Asian (EAS)
AF:
AC:
18
AN:
5098
South Asian (SAS)
AF:
AC:
208
AN:
4768
European-Finnish (FIN)
AF:
AC:
653
AN:
10536
Middle Eastern (MID)
AF:
AC:
23
AN:
294
European-Non Finnish (NFE)
AF:
AC:
2510
AN:
67848
Other (OTH)
AF:
AC:
149
AN:
2096
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.473
Heterozygous variant carriers
0
402
804
1206
1608
2010
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
114
228
342
456
570
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
143
AN:
3478
ClinVar
Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided
- -
Sep 18, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.